Mesa Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Mesa Biotech's estimated annual revenue is currently $3.2M per year.
- Mesa Biotech's estimated revenue per employee is $77,500
- Mesa Biotech's total funding is $39.4M.
Employee Data
- Mesa Biotech has 41 Employees.
- Mesa Biotech grew their employee count by -35% last year.
Mesa Biotech's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP Engineering & Product Development | Reveal Email/Phone |
3 | Co-Founder & Chief Scientific Officer | Reveal Email/Phone |
4 | Co-Founder & Chief Technology Officer | Reveal Email/Phone |
5 | Manager, Manufacturing | Reveal Email/Phone |
6 | Supervisor, Protein Biochemistry | Reveal Email/Phone |
7 | Quality Operations/Continuous Improvement Leadership | Reveal Email/Phone |
8 | Manufacturing Engineer 1 | Reveal Email/Phone |
9 | Chairman | Reveal Email/Phone |
10 | President and CEO | Reveal Email/Phone |
Mesa Biotech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Mesa Biotech?
Mesa Biotech designs, develops, manufactures and commercializes next generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care. Mesaᅢᄁ¬ツᆲ¬トᄁs Acculaᅢᄁ¬ダᅡᄁ System consists of a portable, palm-sized dock and assay-specific test cassettes. This patented system enables healthcare professionals to access actionable, laboratory-quality results at the point-of-care with greater sensitivity and specificity than current infectious disease rapid immunoassay tests. The Accula Flu A/Flu B and the Accula RSV tests have obtained CE Mark in the EU and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA).
keywords:N/A$39.4M
Total Funding
41
Number of Employees
$3.2M
Revenue (est)
-35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mesa Biotech News
Roche Diagnostics, Beckman Coulter, BioMérieux, Mesa Biotech Receive FDA 510(k) Clearances in November. staff reporter, 360Dx, 2020.
Laboratory-Developed Tests (LDTs) Market SWOT Analysis, Key Indicators and Top Key Vendors (Roche, Quidel, Mesa Biotech) | Forecast to 2029.
Global COVID-19 Diagnosis Market Revenue Analysis and Industry Forecast, 2022 to 2028 Top Most Key Players Cepheid, Abbott, Mesa Biotech,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.1M | 41 | -18% | N/A |
#2 | $4.8M | 41 | 8% | N/A |
#3 | $7.5M | 41 | -13% | $269.2M |
#4 | $8.9M | 41 | 3% | N/A |
#5 | $6.7M | 41 | 3% | N/A |